Date of activity: 3/1/2023
Christopher P. Crum, MD
Professor of Pathology, Harvard Medical School
Division of Women’s and Perinatal Pathology
Department of Pathology
Brigham and Women’s Hospital
Objectives:
1. Describe two evolutionary pathways for serous tubal intraepithelial carcinoma (STIC).
2. Describe two possible molecular events leading to rapidly developing high-grade serous carcinoma.
3. Describe two potential opportunities for preventing high-grade serous carcinoma.
Speaker disclosures: Dr. Christopher Crum has NOT had any financial relationships with any ineligible entities within the past 24 months.
***********************************************************************************************************
Planning Committee Disclosure:
The following members have not had any financial relationships with any ineligible entities in the past 24 months: Drs. Rebecca Alvarez, Eleanor Chen, Austin Green, Jose Mantilla, Isaac Miller, Elizabeth Parker, Maria Tretiakova, and Larry True.
The following members disclose financial relations with ineligible entities within the past 24 months: Dr Shreeram Akilesh GoldfinchBio, Inc. (sponsored research); and Dr. Haodong Xu PathomIQ (consultant).
All relevant financial relationships listed have been mitigated.
Grant Acknowledgement: None